Bombus pyrosoma isolate SC7728 linkage group LG8, ASM1482585v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea; Apidae; Bombus; Melanobombus.
Genus-wide characterization of bumblebee genomes provides insights into their evolution and variation in ecological and behavioral traits
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM026132.1.\nAssembly name: ASM1482585v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Chinese Academy of\nAgricultural Sciences on 2020/10/02. The original whole-genome\nshotgun project has the accession JACXIN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Chinese Academy of Agricultural Sciences\nAssembly Date :: DEC-2017\nAssembly Method :: DISCOVAR de novo v. 52488\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 100x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Bombus pyrosoma Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
octopamine receptor beta-3R-like, transcript variant X6
COORDINATES: polyA evidence [ECO:0006239]
octopamine receptor beta-3R-like, transcript variant X7
octopamine receptor beta-3R-like, transcript variant X4
octopamine receptor beta-3R-like, transcript variant X5
octopamine receptor beta-3R-like, transcript variant X1
octopamine receptor beta-3R-like, transcript variant X3
octopamine receptor beta-3R-like, transcript variant X2
octopamine receptor beta-3R-like isoform X3
octopamine receptor beta-3R-like isoform X2
octopamine receptor beta-3R-like isoform X1
octopamine receptor beta-3R-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
octopamine receptor beta-3R-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
octopamine receptor beta-3R-like isoform X4
octopamine receptor beta-1R-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
octopamine receptor beta-1R-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
octopamine receptor beta-1R-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ubiquitin thioesterase trabid, transcript variant X3
ubiquitin thioesterase trabid, transcript variant X2
ubiquitin thioesterase trabid, transcript variant X1
ubiquitin thioesterase trabid isoform X2
ubiquitin thioesterase trabid isoform X1
NADPH-dependent diflavin oxidoreductase 1, transcript variant X4
NADPH-dependent diflavin oxidoreductase 1 isoform X4
NADPH-dependent diflavin oxidoreductase 1, transcript variant X1
NADPH-dependent diflavin oxidoreductase 1, transcript variant X3
NADPH-dependent diflavin oxidoreductase 1, transcript variant X2
equilibrative nucleoside transporter 1 isoform X1
equilibrative nucleoside transporter 1 isoform X2
equilibrative nucleoside transporter 1 isoform X3
E3 ubiquitin-protein transferase MAEA, transcript variant X2
E3 ubiquitin-protein transferase MAEA, transcript variant X1
E3 ubiquitin-protein transferase MAEA isoform X1
E3 ubiquitin-protein transferase MAEA isoform X2
C-terminal-binding protein, transcript variant X5
C-terminal-binding protein, transcript variant X7
C-terminal-binding protein, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
C-terminal-binding protein, transcript variant X1
C-terminal-binding protein, transcript variant X8
C-terminal-binding protein, transcript variant X3
C-terminal-binding protein, transcript variant X2
C-terminal-binding protein, transcript variant X4
C-terminal-binding protein, transcript variant X6
ATP-binding cassette sub-family D member
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
osmotic avoidance abnormal protein 3-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
osmotic avoidance abnormal protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
osmotic avoidance abnormal protein 3-like, transcript variant X4
osmotic avoidance abnormal protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
osmotic avoidance abnormal protein 3-like, transcript variant X1
osmotic avoidance abnormal protein 3-like
zinc finger protein 100-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 100-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 100-like, transcript variant X4
zinc finger protein 100-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
serine-rich adhesin for platelets-like, transcript variant X4
serine-rich adhesin for platelets-like, transcript variant X5
serine-rich adhesin for platelets-like isoform X4
serine-rich adhesin for platelets-like isoform X5
serine-rich adhesin for platelets-like, transcript variant X3
serine-rich adhesin for platelets-like isoform X3
serine-rich adhesin for platelets-like, transcript variant X6
serine-rich adhesin for platelets-like isoform X6
serine-rich adhesin for platelets-like, transcript variant X1
serine-rich adhesin for platelets-like, transcript variant X2
serine-rich adhesin for platelets-like, transcript variant X7
serine-rich adhesin for platelets-like isoform X1
serine-rich adhesin for platelets-like isoform X2
serine-rich adhesin for platelets-like isoform X7
transcriptional activator protein Pur-beta, transcript variant X4
transcriptional activator protein Pur-beta isoform X4
transcriptional activator protein Pur-beta, transcript variant X1
transcriptional activator protein Pur-beta, transcript variant X6
transcriptional activator protein Pur-beta, transcript variant X2
transcriptional activator protein Pur-beta isoform X1
transcriptional activator protein Pur-beta isoform X2
transcriptional activator protein Pur-beta isoform X6
transcriptional activator protein Pur-beta, transcript variant X3
transcriptional activator protein Pur-beta isoform X3
transcriptional activator protein Pur-beta, transcript variant X5
transcriptional activator protein Pur-beta isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nucleolar protein 14 homolog
atrial natriuretic peptide receptor 1, transcript variant X2
atrial natriuretic peptide receptor 1, transcript variant X1
atrial natriuretic peptide receptor 1, transcript variant X4
atrial natriuretic peptide receptor 1, transcript variant X3
atrial natriuretic peptide receptor 1 isoform X2
atrial natriuretic peptide receptor 1 isoform X1
atrial natriuretic peptide receptor 1 isoform X4
atrial natriuretic peptide receptor 1 isoform X3
probable 39S ribosomal protein L23, mitochondrial, transcript variant X1
probable tubulin polyglutamylase TTLL1 isoform X1
probable 39S ribosomal protein L23, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable tubulin polyglutamylase TTLL1 isoform X2
uncharacterized protein CG13380, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein CG13380, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein CG13380, transcript variant X1
uncharacterized protein CG13380, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein CG13380, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein CG13380, transcript variant X6
probable 39S ribosomal protein L23, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable 39S ribosomal protein L23, mitochondrial, transcript variant X4
probable 39S ribosomal protein L23, mitochondrial, transcript variant X5
probable 39S ribosomal protein L23, mitochondrial isoform X3
uncharacterized LOC122570402, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122570402, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
potassium channel subfamily K member 18-like, transcript variant X5
potassium channel subfamily K member 18-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
potassium channel subfamily K member 18-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium channel subfamily K member 18-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium channel subfamily K member 18-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium channel subfamily K member 18-like isoform X2
potassium channel subfamily K member 18-like isoform X1
uncharacterized LOC122570398, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122570398, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122570398, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122570398, transcript variant X4
uncharacterized LOC122570398, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TWiK family of potassium channels protein 18-like
uncharacterized LOC122570386, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122570386, transcript variant X1
uncharacterized protein LOC122570386 isoform X1
uncharacterized LOC122570386, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC122570386 isoform X2
uncharacterized LOC122570398, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122570387, transcript variant X4
uncharacterized LOC122570387, transcript variant X5
uncharacterized LOC122570387, transcript variant X3
uncharacterized LOC122570387, transcript variant X2
uncharacterized LOC122570387, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RNA polymerase II subunit A C-terminal domain phosphatase SSU72
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122570395, transcript variant X1
uncharacterized LOC122570395, transcript variant X2
uncharacterized protein LOC122570395 isoform X1
uncharacterized protein LOC122570395 isoform X2
uncharacterized LOC122570391, transcript variant X1
uncharacterized LOC122570391, transcript variant X2
uncharacterized protein LOC122570391 isoform X2
uncharacterized protein LOC122570391 isoform X1
zinc finger protein 724-like, transcript variant X2
zinc finger protein 724-like, transcript variant X5
zinc finger protein 724-like, transcript variant X1
zinc finger protein 724-like, transcript variant X4
zinc finger protein 724-like, transcript variant X3
threonine--tRNA ligase 1, cytoplasmic, transcript variant X2
threonine--tRNA ligase 1, cytoplasmic, transcript variant X1
threonine--tRNA ligase 1, cytoplasmic isoform X2
threonine--tRNA ligase 1, cytoplasmic, transcript variant X3
threonine--tRNA ligase 1, cytoplasmic isoform X1
threonine--tRNA ligase 1, cytoplasmic isoform X3
zinc finger protein DPF3, transcript variant X1
zinc finger protein DPF3, transcript variant X3
zinc finger protein DPF3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ribosomal protein S6 kinase alpha-5-like, transcript variant X3
ribosomal protein S6 kinase alpha-5-like, transcript variant X1
ribosomal protein S6 kinase alpha-5-like, transcript variant X2
ribosomal protein S6 kinase alpha-5-like isoform X2
ribosomal protein S6 kinase alpha-5-like isoform X1
uncharacterized LOC122570419, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122570419, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
neutral ceramidase, transcript variant X4
neutral ceramidase, transcript variant X1
neutral ceramidase, transcript variant X2
neutral ceramidase, transcript variant X3
neutral ceramidase, transcript variant X5
cuticle protein 19-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cuticle protein 19-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cuticle protein 19-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cuticle protein 19-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X3
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X4
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X2
uncharacterized LOC122570418, transcript variant X4
uncharacterized LOC122570418, transcript variant X3
uncharacterized LOC122570418, transcript variant X2
uncharacterized LOC122570418, transcript variant X1
uncharacterized protein LOC122570418 isoform X2
uncharacterized protein LOC122570418 isoform X1
uncharacterized LOC122570412, transcript variant X2
uncharacterized LOC122570412, transcript variant X1
uncharacterized LOC122570412, transcript variant X5
uncharacterized LOC122570412, transcript variant X3
uncharacterized protein LOC122570412 isoform X1
uncharacterized protein LOC122570412 isoform X2
uncharacterized LOC122570412, transcript variant X4
uncharacterized protein LOC122570412 isoform X3
cyclic AMP-responsive element-binding protein 3-like protein 2, transcript variant X1
cyclic AMP-responsive element-binding protein 3-like protein 2, transcript variant X2
cyclic AMP-responsive element-binding protein 3-like protein 2 isoform X1
cyclic AMP-responsive element-binding protein 3-like protein 2, transcript variant X3
cyclic AMP-responsive element-binding protein 3-like protein 2 isoform X2
cyclic AMP-responsive element-binding protein 3-like protein 2, transcript variant X6
cyclic AMP-responsive element-binding protein 3-like protein 2, transcript variant X5
cyclic AMP-responsive element-binding protein 3-like protein 2, transcript variant X7
cyclic AMP-responsive element-binding protein 3-like protein 2, transcript variant X4
cyclic AMP-responsive element-binding protein 3-like protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
transient-receptor-potential-like protein, transcript variant X1
transient-receptor-potential-like protein, transcript variant X2
transient-receptor-potential-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
insulin-like growth factor I, juvenile form, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
insulin-like growth factor I, juvenile form, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
insulin-like growth factor I, juvenile form, transcript variant X2
insulin-like growth factor I, juvenile form, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
insulin-like growth factor I, juvenile form, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
insulin-like growth factor I, juvenile form
ras-related and estrogen-regulated growth inhibitor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor, transcript variant X1
ras-related and estrogen-regulated growth inhibitor
Bardet-Biedl syndrome 2 protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Bardet-Biedl syndrome 2 protein homolog isoform X1
Bardet-Biedl syndrome 2 protein homolog, transcript variant X2
Bardet-Biedl syndrome 2 protein homolog isoform X2
apoptosis-inducing factor 3-like, transcript variant X3
apoptosis-inducing factor 3-like isoform X3
apoptosis-inducing factor 3-like, transcript variant X1
apoptosis-inducing factor 3-like, transcript variant X2
apoptosis-inducing factor 3-like isoform X1
apoptosis-inducing factor 3-like isoform X2
cytoplasmic polyadenylation element-binding protein 2-like, transcript variant X3
cytoplasmic polyadenylation element-binding protein 2-like, transcript variant X2
cytoplasmic polyadenylation element-binding protein 2-like, transcript variant X1
cytoplasmic polyadenylation element-binding protein 2-like isoform X2
cytoplasmic polyadenylation element-binding protein 2-like isoform X1
cytoplasmic polyadenylation element-binding protein 2-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
nuclear envelope integral membrane protein 1, transcript variant X1
nuclear envelope integral membrane protein 1, transcript variant X2
nuclear envelope integral membrane protein 1 isoform X1
nuclear envelope integral membrane protein 1 isoform X2
probable sodium/potassium/calcium exchanger CG1090, transcript variant X2
probable sodium/potassium/calcium exchanger CG1090, transcript variant X1
probable sodium/potassium/calcium exchanger CG1090 isoform X2
probable sodium/potassium/calcium exchanger CG1090 isoform X1
COMM domain-containing protein 4, transcript variant X2
COMM domain-containing protein 4, transcript variant X1
uncharacterized LOC122570000, transcript variant X3
uncharacterized LOC122570000, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122570000, transcript variant X2
uncharacterized protein LOC122570000 isoform X2
uncharacterized protein LOC122570000 isoform X1
uncharacterized LOC122569994, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122569994, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122569994, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122569994, transcript variant X10
uncharacterized LOC122569994, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122569994, transcript variant X7
uncharacterized LOC122569994, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122569994, transcript variant X1
uncharacterized LOC122569994, transcript variant X6
uncharacterized LOC122569994, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC122569994 isoform X1
uncharacterized protein LOC122569994 isoform X2
COMM domain-containing protein 4, transcript variant X3
microtubule-associated protein futsch-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: microtubule-associated protein futsch-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
calcium-independent phospholipase A2-gamma-like, transcript variant X1
calcium-independent phospholipase A2-gamma-like, transcript variant X2
calcium-independent phospholipase A2-gamma-like isoform X1
calcium-independent phospholipase A2-gamma-like isoform X2
splicing factor YJU2, transcript variant X1
splicing factor YJU2, transcript variant X2
uncharacterized LOC122570001, transcript variant X1
uncharacterized LOC122570001, transcript variant X2
FHIP family protein AAEL005291-like, transcript variant X1
FHIP family protein AAEL005291-like, transcript variant X2
FHIP family protein AAEL005291-like, transcript variant X3
FHIP family protein AAEL005291-like, transcript variant X4
FHIP family protein AAEL005291-like isoform X1
FHIP family protein AAEL005291-like isoform X2
FHIP family protein AAEL005291-like isoform X3
RILP-like protein homolog, transcript variant X5
RILP-like protein homolog, transcript variant X2
RILP-like protein homolog, transcript variant X1
RILP-like protein homolog, transcript variant X3
RILP-like protein homolog, transcript variant X4
ER degradation-enhancing alpha-mannosidase-like protein 2
LOW QUALITY PROTEIN: ER degradation-enhancing alpha-mannosidase-like protein 2
vesicular inhibitory amino acid transporter, transcript variant X2
vesicular inhibitory amino acid transporter, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
vesicular inhibitory amino acid transporter
ubiquitin carboxyl-terminal hydrolase 20
eukaryotic translation initiation factor 2 subunit 1, transcript variant X1
eukaryotic translation initiation factor 2 subunit 1, transcript variant X2
eukaryotic translation initiation factor 2 subunit 1
sister chromatid cohesion protein PDS5 homolog B, transcript variant X1
sister chromatid cohesion protein PDS5 homolog B, transcript variant X2
sister chromatid cohesion protein PDS5 homolog B, transcript variant X3
sister chromatid cohesion protein PDS5 homolog B, transcript variant X4
sister chromatid cohesion protein PDS5 homolog B-B isoform X1
sister chromatid cohesion protein PDS5 homolog B isoform X3
sister chromatid cohesion protein PDS5 homolog B isoform X2
sister chromatid cohesion protein PDS5 homolog B isoform X4
probable ATP-dependent RNA helicase DDX27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
reticulon-4-interacting protein 1 homolog, mitochondrial-like, transcript variant X1
reticulon-4-interacting protein 1 homolog, mitochondrial-like, transcript variant X2
reticulon-4-interacting protein 1 homolog, mitochondrial-like, transcript variant X3
reticulon-4-interacting protein 1 homolog, mitochondrial-like
uncharacterized LOC122570054, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122570054, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122570054, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122570054, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122570054, transcript variant X9
uncharacterized LOC122570054, transcript variant X10
uncharacterized LOC122570054, transcript variant X2
uncharacterized LOC122570054, transcript variant X3
uncharacterized LOC122570054, transcript variant X4
uncharacterized LOC122570054, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nucleolar protein 4-like, transcript variant X2
nucleolar protein 4-like, transcript variant X6
nucleolar protein 4-like, transcript variant X5
nucleolar protein 4-like, transcript variant X3
nucleolar protein 4-like, transcript variant X4
nucleolar protein 4-like, transcript variant X1
uncharacterized LOC122570348, transcript variant X3
uncharacterized LOC122570348, transcript variant X5
uncharacterized LOC122570348, transcript variant X2
uncharacterized LOC122570348, transcript variant X1
uncharacterized LOC122570348, transcript variant X6
uncharacterized LOC122570348, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC122570349, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122570349, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122570349, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ATP-dependent RNA helicase DDX24, transcript variant X1
ATP-dependent RNA helicase DDX24, transcript variant X3
ATP-dependent RNA helicase DDX24, transcript variant X2
conserved oligomeric Golgi complex subunit 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
39S ribosomal protein L48, mitochondrial, transcript variant X2
39S ribosomal protein L48, mitochondrial, transcript variant X1
39S ribosomal protein L48, mitochondrial isoform X1
39S ribosomal protein L48, mitochondrial isoform X2
WD repeat-containing and planar cell polarity effector protein fritz, transcript variant X1
WD repeat-containing and planar cell polarity effector protein fritz, transcript variant X2
WD repeat-containing and planar cell polarity effector protein fritz, transcript variant X3
WD repeat-containing and planar cell polarity effector protein fritz isoform X1
WD repeat-containing and planar cell polarity effector protein fritz, transcript variant X4
WD repeat-containing and planar cell polarity effector protein fritz isoform X2
uncharacterized LOC122570443, transcript variant X2
uncharacterized LOC122570443, transcript variant X1
uncharacterized protein LOC122570443 isoform X1
uncharacterized protein LOC122570443 isoform X2
leucine-rich melanocyte differentiation-associated protein-like, transcript variant X1
leucine-rich melanocyte differentiation-associated protein-like, transcript variant X2
leucine-rich melanocyte differentiation-associated protein-like isoform X2
leucine-rich melanocyte differentiation-associated protein-like isoform X1
synaptic vesicle glycoprotein 2B-like, transcript variant X2
synaptic vesicle glycoprotein 2B-like, transcript variant X1
synaptic vesicle glycoprotein 2B-like isoform X1
synaptic vesicle glycoprotein 2B-like, transcript variant X3
synaptic vesicle glycoprotein 2B-like isoform X2
synaptic vesicle glycoprotein 2B-like isoform X3
sorting nexin-4-like, transcript variant X1
sorting nexin-4-like, transcript variant X3
sorting nexin-4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sorting nexin-4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
S phase cyclin A-associated protein in the endoplasmic reticulum, transcript variant X1
S phase cyclin A-associated protein in the endoplasmic reticulum isoform X1
S phase cyclin A-associated protein in the endoplasmic reticulum, transcript variant X3
S phase cyclin A-associated protein in the endoplasmic reticulum isoform X3
S phase cyclin A-associated protein in the endoplasmic reticulum, transcript variant X2
S phase cyclin A-associated protein in the endoplasmic reticulum isoform X2
ubiquitin-conjugating enzyme E2 N, transcript variant X2
ubiquitin-conjugating enzyme E2 N, transcript variant X1
ras-specific guanine nucleotide-releasing factor 1-like, transcript variant X2
ras-specific guanine nucleotide-releasing factor 1-like, transcript variant X3
ras-specific guanine nucleotide-releasing factor 1-like isoform X2
ras-specific guanine nucleotide-releasing factor 1-like isoform X3
ras-specific guanine nucleotide-releasing factor 1-like, transcript variant X1
ras-specific guanine nucleotide-releasing factor 1-like, transcript variant X4
ras-specific guanine nucleotide-releasing factor 2-like isoform X1
ras-specific guanine nucleotide-releasing factor 2-like isoform X4
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X5
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X1
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X3
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X4
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X2
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X6
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X1
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X3
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X2
ATP-dependent helicase brm-like, transcript variant X10
ATP-dependent helicase brm-like, transcript variant X8
uncharacterized LOC122570218, transcript variant X2
uncharacterized LOC122570218, transcript variant X1
ATP-dependent helicase brm-like, transcript variant X4
ATP-dependent helicase brm-like, transcript variant X12
ATP-dependent helicase brm-like, transcript variant X11
ATP-dependent helicase brm-like, transcript variant X13
ATP-dependent helicase brm-like, transcript variant X9
ATP-dependent helicase brm-like, transcript variant X6
ATP-dependent helicase brm-like, transcript variant X7
ATP-dependent helicase brm-like, transcript variant X1
ATP-dependent helicase brm-like, transcript variant X3
ATP-dependent helicase brm-like, transcript variant X5
ATP-dependent helicase brm-like, transcript variant X2
cysteine and histidine-rich protein 1 homolog
sporulation-specific protein 15, transcript variant X4
sporulation-specific protein 15, transcript variant X3
sporulation-specific protein 15, transcript variant X2
sporulation-specific protein 15, transcript variant X1
sporulation-specific protein 15 isoform X2
sporulation-specific protein 15 isoform X1
uncharacterized LOC122570214, transcript variant X3
uncharacterized LOC122570214, transcript variant X9
uncharacterized LOC122570214, transcript variant X10
uncharacterized LOC122570214, transcript variant X5
uncharacterized LOC122570214, transcript variant X7
uncharacterized LOC122570214, transcript variant X6
uncharacterized LOC122570214, transcript variant X8
uncharacterized LOC122570214, transcript variant X11
uncharacterized protein LOC122570214 isoform X2
uncharacterized LOC122570214, transcript variant X1
uncharacterized LOC122570214, transcript variant X2
uncharacterized LOC122570214, transcript variant X4
uncharacterized protein LOC122570214 isoform X3
uncharacterized protein LOC122570214 isoform X1
endoplasmic reticulum metallopeptidase 1-like, transcript variant X2
endoplasmic reticulum metallopeptidase 1-like, transcript variant X1
endoplasmic reticulum metallopeptidase 1-like
trimeric intracellular cation channel type 1B.1
uncharacterized LOC122570201, transcript variant X3
uncharacterized LOC122570201, transcript variant X2
uncharacterized LOC122570201, transcript variant X1
uncharacterized protein LOC122570201 isoform X3
uncharacterized protein LOC122570201 isoform X2
uncharacterized protein LOC122570201 isoform X1
uncharacterized LOC122570209, transcript variant X3
uncharacterized LOC122570209, transcript variant X2
uncharacterized LOC122570209, transcript variant X1
uncharacterized protein LOC122570209 isoform X3
uncharacterized protein LOC122570209 isoform X2
uncharacterized protein LOC122570209 isoform X1
mitogen-activated protein kinase p38a-like, transcript variant X2
mitogen-activated protein kinase p38a-like, transcript variant X3
mitogen-activated protein kinase p38a-like, transcript variant X1
mitogen-activated protein kinase p38b-like isoform X2
mitogen-activated protein kinase p38b-like isoform X1
mitogen-activated protein kinase p38a-like isoform X3
ATPase ASNA1 homolog, transcript variant X3
ATPase ASNA1 homolog, transcript variant X2
ATPase ASNA1 homolog, transcript variant X1
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial, transcript variant X2
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial, transcript variant X1
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial isoform X2
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial isoform X1
Golgi SNAP receptor complex member 1, transcript variant X1
Golgi SNAP receptor complex member 1, transcript variant X2
Golgi SNAP receptor complex member 1 isoform X1
Golgi SNAP receptor complex member 1 isoform X2
protein strawberry notch, transcript variant X2
protein strawberry notch, transcript variant X1
histone-lysine N-methyltransferase PR-Set7, transcript variant X2
histone-lysine N-methyltransferase PR-Set7, transcript variant X3
histone-lysine N-methyltransferase PR-Set7, transcript variant X1
histone-lysine N-methyltransferase PR-Set7 isoform X1
histone-lysine N-methyltransferase PR-Set7 isoform X2
histone-lysine N-methyltransferase PR-Set7 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
vacuolar protein sorting-associated protein 26C
protein mono-ADP-ribosyltransferase PARP16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein mono-ADP-ribosyltransferase PARP16, transcript variant X3
protein mono-ADP-ribosyltransferase PARP16, transcript variant X1
protein mono-ADP-ribosyltransferase PARP16 isoform X2
protein mono-ADP-ribosyltransferase PARP16 isoform X1
myocyte-specific enhancer factor 2, transcript variant X9
myocyte-specific enhancer factor 2, transcript variant X10
myocyte-specific enhancer factor 2, transcript variant X8
myocyte-specific enhancer factor 2, transcript variant X11
myocyte-specific enhancer factor 2, transcript variant X7
myocyte-specific enhancer factor 2, transcript variant X1
myocyte-specific enhancer factor 2, transcript variant X2
myocyte-specific enhancer factor 2, transcript variant X5
myocyte-specific enhancer factor 2, transcript variant X6
myocyte-specific enhancer factor 2, transcript variant X4
myocyte-specific enhancer factor 2, transcript variant X3
myocyte-specific enhancer factor 2 isoform X1
myocyte-specific enhancer factor 2 isoform X4
myocyte-specific enhancer factor 2 isoform X5
myocyte-specific enhancer factor 2 isoform X2
myocyte-specific enhancer factor 2 isoform X3
myocyte-specific enhancer factor 2 isoform X6
polyglutamine-binding protein 1, transcript variant X1
polyglutamine-binding protein 1, transcript variant X3
polyglutamine-binding protein 1 isoform X3
polyglutamine-binding protein 1 isoform X1
polyglutamine-binding protein 1, transcript variant X2
polyglutamine-binding protein 1 isoform X2
transient receptor potential cation channel trpm, transcript variant X1
transient receptor potential cation channel trpm, transcript variant X5
transient receptor potential cation channel trpm, transcript variant X3
transient receptor potential cation channel trpm, transcript variant X2
transient receptor potential cation channel trpm, transcript variant X4
transient receptor potential cation channel trpm isoform X2
transient receptor potential cation channel trpm isoform X4
transient receptor potential cation channel trpm isoform X1
transient receptor potential cation channel trpm isoform X5
transient receptor potential cation channel trpm isoform X3
chymotrypsin-like elastase family member 2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 567-like, transcript variant X2
zinc finger protein 567-like, transcript variant X1
zinc finger protein 567-like, transcript variant X4
zinc finger protein 567-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122569926, transcript variant X5
uncharacterized LOC122569926, transcript variant X3
uncharacterized LOC122569926, transcript variant X4
uncharacterized LOC122569926, transcript variant X2
uncharacterized LOC122569926, transcript variant X1
39S ribosomal protein L39, mitochondrial, transcript variant X1
39S ribosomal protein L39, mitochondrial, transcript variant X2
39S ribosomal protein L39, mitochondrial
DNA-directed RNA polymerase III subunit RPC10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DNA-directed RNA polymerase III subunit RPC10, transcript variant X2
DNA-directed RNA polymerase III subunit RPC10
yrdC domain-containing protein, mitochondrial
spectrin beta chain, non-erythrocytic 5, transcript variant X3
jerky protein homolog-like, transcript variant X5
jerky protein homolog-like, transcript variant X4
jerky protein homolog-like, transcript variant X3
jerky protein homolog-like, transcript variant X2
jerky protein homolog-like, transcript variant X1
spectrin beta chain, non-erythrocytic 5, transcript variant X1
spectrin beta chain, non-erythrocytic 5, transcript variant X2
spectrin beta chain, non-erythrocytic 5 isoform X1
spectrin beta chain, non-erythrocytic 5 isoform X2
spectrin beta chain, non-erythrocytic 5 isoform X3
uncharacterized LOC122570049, transcript variant X1
uncharacterized LOC122570049, transcript variant X2
uncharacterized LOC122570048, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122570048, transcript variant X7
uncharacterized LOC122570048, transcript variant X2
uncharacterized LOC122570048, transcript variant X8
uncharacterized LOC122570048, transcript variant X10
uncharacterized LOC122570048, transcript variant X3
uncharacterized LOC122570048, transcript variant X1
uncharacterized LOC122570048, transcript variant X5
uncharacterized LOC122570048, transcript variant X6
uncharacterized LOC122570048, transcript variant X9
uncharacterized LOC122570048, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X1
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X3
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X2
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X4
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X5
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X6
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X8
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X7
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X9
mitogen-activated protein kinase kinase kinase kinase 5 isoform X1
mitogen-activated protein kinase kinase kinase kinase 5 isoform X2
mitogen-activated protein kinase kinase kinase kinase 3 isoform X3
mitogen-activated protein kinase kinase kinase kinase 5 isoform X5
mitogen-activated protein kinase kinase kinase kinase 5 isoform X4
mitogen-activated protein kinase kinase kinase kinase 5 isoform X6
pleckstrin homology domain-containing family G member 3, transcript variant X2
pleckstrin homology domain-containing family G member 3, transcript variant X6
pleckstrin homology domain-containing family G member 3, transcript variant X1
pleckstrin homology domain-containing family G member 3, transcript variant X4
pleckstrin homology domain-containing family G member 3, transcript variant X5
pleckstrin homology domain-containing family G member 3, transcript variant X3
pleckstrin homology domain-containing family G member 1 isoform X3
uncharacterized protein LOC122570040 isoform X1
uncharacterized protein LOC122570040 isoform X2
pleckstrin homology domain-containing family G member 3, transcript variant X8
pleckstrin homology domain-containing family G member 3, transcript variant X7
pleckstrin homology domain-containing family G member 3 isoform X4
uncharacterized LOC122570050, transcript variant X1
uncharacterized LOC122570050, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ras-related protein Rap1, transcript variant X6
ras-related protein Rap1, transcript variant X5
ras-related protein Rap1, transcript variant X1
ras-related protein Rap1, transcript variant X2
ras-related protein Rap1, transcript variant X4
ras-related protein Rap1, transcript variant X3
IQ motif and SEC7 domain-containing protein 2, transcript variant X6
IQ motif and SEC7 domain-containing protein 2, transcript variant X4
IQ motif and SEC7 domain-containing protein 2, transcript variant X1
IQ motif and SEC7 domain-containing protein 2 isoform X1
IQ motif and SEC7 domain-containing protein 2 isoform X5
IQ motif and SEC7 domain-containing protein 2 isoform X3
IQ motif and SEC7 domain-containing protein 2, transcript variant X5
IQ motif and SEC7 domain-containing protein 2 isoform X4
IQ motif and SEC7 domain-containing protein 2, transcript variant X2
IQ motif and SEC7 domain-containing protein 2, transcript variant X3
IQ motif and SEC7 domain-containing protein 1 isoform X2
IQ motif and SEC7 domain-containing protein 2, transcript variant X7
IQ motif and SEC7 domain-containing protein 2 isoform X6
T-complex protein 1 subunit zeta, transcript variant X2
T-complex protein 1 subunit zeta isoform X2
NAD-dependent protein deacylase Sirt4, transcript variant X2
NAD-dependent protein deacylase Sirt4, transcript variant X1
NAD-dependent protein deacylase Sirt4 isoform X1
NAD-dependent protein deacylase Sirt4 isoform X2
T-complex protein 1 subunit zeta, transcript variant X1
T-complex protein 1 subunit zeta isoform X1
uncharacterized LOC122570100, transcript variant X5
uncharacterized LOC122570100, transcript variant X2
uncharacterized LOC122570100, transcript variant X3
uncharacterized LOC122570100, transcript variant X9
uncharacterized LOC122570100, transcript variant X7
uncharacterized LOC122570100, transcript variant X8
uncharacterized LOC122570100, transcript variant X1
uncharacterized LOC122570100, transcript variant X4
uncharacterized LOC122570100, transcript variant X6
uncharacterized protein LOC122570100 isoform X2
uncharacterized protein LOC122570100 isoform X3
uncharacterized protein LOC122570100 isoform X4
uncharacterized protein LOC122570100 isoform X1
eukaryotic translation initiation factor 4E transporter-like, transcript variant X3
eukaryotic translation initiation factor 4E transporter-like, transcript variant X2
eukaryotic translation initiation factor 4E transporter-like, transcript variant X6
eukaryotic translation initiation factor 4E transporter-like, transcript variant X5
eukaryotic translation initiation factor 4E transporter-like, transcript variant X1
eukaryotic translation initiation factor 4E transporter-like, transcript variant X4
eukaryotic translation initiation factor 4E transporter-like isoform X6
eukaryotic translation initiation factor 4E transporter-like isoform X5
eukaryotic translation initiation factor 4E transporter-like isoform X2
eukaryotic translation initiation factor 4E transporter-like isoform X4
eukaryotic translation initiation factor 4E transporter-like isoform X1
eukaryotic translation initiation factor 4E transporter-like, transcript variant X7
coiled-coil domain-containing protein 174, transcript variant X3
serine-aspartate repeat-containing protein I-like, transcript variant X3
serine-aspartate repeat-containing protein I-like, transcript variant X2
serine-aspartate repeat-containing protein I-like, transcript variant X1
serine-aspartate repeat-containing protein I-like
coiled-coil domain-containing protein 174, transcript variant X2
coiled-coil domain-containing protein 174, transcript variant X1
coiled-coil domain-containing protein 174
non-structural maintenance of chromosomes element 1 homolog, transcript variant X5
non-structural maintenance of chromosomes element 1 homolog, transcript variant X7
non-structural maintenance of chromosomes element 1 homolog, transcript variant X11
non-structural maintenance of chromosomes element 1 homolog, transcript variant X2
non-structural maintenance of chromosomes element 1 homolog, transcript variant X8
non-structural maintenance of chromosomes element 1 homolog, transcript variant X9
non-structural maintenance of chromosomes element 1 homolog, transcript variant X1
non-structural maintenance of chromosomes element 1 homolog, transcript variant X4
non-structural maintenance of chromosomes element 1 homolog, transcript variant X10
non-structural maintenance of chromosomes element 1 homolog, transcript variant X3
non-structural maintenance of chromosomes element 1 homolog, transcript variant X6
non-structural maintenance of chromosomes element 1 homolog
calcium/calmodulin-dependent protein kinase type 1, transcript variant X1
calcium/calmodulin-dependent protein kinase type 1, transcript variant X2
calcium/calmodulin-dependent protein kinase type 1 isoform X1
calcium/calmodulin-dependent protein kinase type 1 isoform X2
eukaryotic translation initiation factor 3 subunit H
uncharacterized LOC122569961, transcript variant X1
uncharacterized LOC122569961, transcript variant X2
uncharacterized protein LOC122569961 isoform X1
uncharacterized protein LOC122569961 isoform X2
uncharacterized LOC122569961, transcript variant X3
uncharacterized protein LOC122569961 isoform X3
putative uncharacterized protein DDB_G0277255, transcript variant X2
putative uncharacterized protein DDB_G0277255, transcript variant X3
putative uncharacterized protein DDB_G0277255, transcript variant X1
putative uncharacterized protein DDB_G0277255
plasminogen activator inhibitor 1 RNA-binding protein-like
integrator complex subunit 12-like, transcript variant X2
integrator complex subunit 12-like, transcript variant X1
integrator complex subunit 12-like, transcript variant X5
integrator complex subunit 12-like, transcript variant X3
integrator complex subunit 12-like, transcript variant X4
integrator complex subunit 12-like isoform X2
integrator complex subunit 12-like isoform X1
integrator complex subunit 12-like isoform X3
integrator complex subunit 12-like isoform X4
integrator complex subunit 12-like, transcript variant X6
integrator complex subunit 12-like isoform X5
protein BCL9 homolog, transcript variant X1
protein BCL9 homolog, transcript variant X2
zinc finger Ran-binding domain-containing protein 2, transcript variant X4
zinc finger Ran-binding domain-containing protein 2, transcript variant X3
zinc finger Ran-binding domain-containing protein 2, transcript variant X2
zinc finger Ran-binding domain-containing protein 2 isoform X2
zinc finger Ran-binding domain-containing protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger Ran-binding domain-containing protein 2 isoform X1
ubiquitin-fold modifier 1, transcript variant X3
ubiquitin-fold modifier 1, transcript variant X2
ubiquitin-fold modifier 1, transcript variant X1
TBC1 domain family member 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TBC1 domain family member 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122570313, transcript variant X2
uncharacterized LOC122570313, transcript variant X3
uncharacterized LOC122570313, transcript variant X1
uncharacterized LOC122570313, transcript variant X5
uncharacterized LOC122570313, transcript variant X4
uncharacterized protein LOC122570313 isoform X4
uncharacterized protein LOC122570313 isoform X2
uncharacterized protein LOC122570313 isoform X3
uncharacterized protein LOC122570313 isoform X1
uncharacterized LOC122570321, transcript variant X1
uncharacterized LOC122570321, transcript variant X2
uncharacterized LOC122570321, transcript variant X3
arginine/serine-rich coiled-coil protein 2-like, transcript variant X1
arginine/serine-rich coiled-coil protein 2-like isoform X1
arginine/serine-rich coiled-coil protein 2-like, transcript variant X2
arginine/serine-rich coiled-coil protein 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
LIM domain kinase 1, transcript variant X2
LIM domain kinase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LIM domain kinase 1, transcript variant X4
LIM domain kinase 1, transcript variant X1
LIM domain kinase 1, transcript variant X3
LIM domain kinase 1, transcript variant X5
optomotor-blind protein, transcript variant X1
optomotor-blind protein, transcript variant X2
optomotor-blind protein, transcript variant X3
coiled-coil domain-containing protein 86
uncharacterized LOC122570371, transcript variant X5
uncharacterized LOC122570371, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122570371, transcript variant X1
uncharacterized LOC122570371, transcript variant X3
uncharacterized LOC122570371, transcript variant X2
uncharacterized LOC122570371, transcript variant X7
uncharacterized protein LOC122570371 isoform X3
uncharacterized protein LOC122570371 isoform X2
uncharacterized protein LOC122570371 isoform X1
uncharacterized protein LOC122570371 isoform X5
uncharacterized LOC122570371, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC122570371 isoform X4
uncharacterized LOC122570135, transcript variant X3
uncharacterized LOC122570135, transcript variant X1
uncharacterized LOC122570135, transcript variant X2
uncharacterized protein LOC122570135 isoform X2
uncharacterized protein LOC122570135 isoform X1
U3 small nucleolar ribonucleoprotein protein MPP10
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X6
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X11
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X8
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X10
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X9
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X5
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X7
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X3
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X2
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X1
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X4
aryl hydrocarbon receptor nuclear translocator homolog isoform X10
aryl hydrocarbon receptor nuclear translocator homolog isoform X7
aryl hydrocarbon receptor nuclear translocator homolog isoform X9
aryl hydrocarbon receptor nuclear translocator homolog isoform X6
aryl hydrocarbon receptor nuclear translocator homolog isoform X5
aryl hydrocarbon receptor nuclear translocator homolog isoform X11
aryl hydrocarbon receptor nuclear translocator homolog isoform X8
aryl hydrocarbon receptor nuclear translocator homolog isoform X2
aryl hydrocarbon receptor nuclear translocator homolog isoform X3
aryl hydrocarbon receptor nuclear translocator homolog isoform X4
aryl hydrocarbon receptor nuclear translocator homolog isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nipped-B-like protein
coiled-coil domain-containing protein 112-like
GAS2-like protein pickled eggs, transcript variant X1
GAS2-like protein pickled eggs, transcript variant X2
GAS2-like protein pickled eggs isoform X1
GAS2-like protein pickled eggs isoform X2
uncharacterized LOC122570369, transcript variant X1
uncharacterized LOC122570369, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC122570369 isoform X1
uncharacterized protein LOC122570369 isoform X2
uncharacterized LOC122570369, transcript variant X3
uncharacterized LOC122570369, transcript variant X4
uncharacterized LOC122570061, transcript variant X4
uncharacterized LOC122570061, transcript variant X3
uncharacterized LOC122570061, transcript variant X1
uncharacterized LOC122570061, transcript variant X2
uncharacterized LOC122570072, transcript variant X2
uncharacterized LOC122570072, transcript variant X1
microtubule-associated protein futsch, transcript variant X2
microtubule-associated protein futsch, transcript variant X1
microtubule-associated protein futsch, transcript variant X3
microtubule-associated protein futsch isoform X2
microtubule-associated protein futsch isoform X3
microtubule-associated protein futsch isoform X1
uncharacterized LOC122570057, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122570057, transcript variant X19
uncharacterized LOC122570057, transcript variant X15
uncharacterized LOC122570057, transcript variant X18
uncharacterized LOC122570057, transcript variant X17
uncharacterized LOC122570057, transcript variant X16
uncharacterized LOC122570057, transcript variant X13
uncharacterized LOC122570057, transcript variant X12
uncharacterized LOC122570057, transcript variant X1
uncharacterized LOC122570057, transcript variant X3
uncharacterized LOC122570057, transcript variant X2
uncharacterized LOC122570057, transcript variant X4
uncharacterized LOC122570057, transcript variant X9
uncharacterized LOC122570057, transcript variant X5
uncharacterized LOC122570057, transcript variant X7
uncharacterized LOC122570057, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122570057, transcript variant X8
uncharacterized LOC122570057, transcript variant X14
uncharacterized LOC122570057, transcript variant X11
uncharacterized LOC122570057, transcript variant X6
uncharacterized protein LOC122570057 isoform X1
uncharacterized protein LOC122570057 isoform X2
mitochondrial amidoxime-reducing component 1-like, transcript variant X2
mitochondrial amidoxime-reducing component 1-like, transcript variant X1
mitochondrial amidoxime-reducing component 1-like isoform X2
mitochondrial amidoxime-reducing component 1-like isoform X1
protein kinase C-binding protein NELL1-like, transcript variant X2
protein kinase C-binding protein NELL1-like, transcript variant X1
protein kinase C-binding protein NELL1-like, transcript variant X3
protein kinase C-binding protein NELL1-like, transcript variant X4
protein kinase C-binding protein NELL1-like isoform X4
protein kinase C-binding protein NELL1-like isoform X1
protein kinase C-binding protein NELL1-like isoform X3
protein kinase C-binding protein NELL1-like isoform X2
CAPA peptides-like, transcript variant X1
CAPA peptides-like, transcript variant X2
leucine-rich repeat-containing protein 24-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat-containing protein 24-like, transcript variant X5
leucine-rich repeat-containing protein 24-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine-rich repeat-containing protein 24-like, transcript variant X4
leucine-rich repeat-containing protein 24-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine-rich repeat-containing protein 24-like, transcript variant X2
leucine-rich repeat-containing protein 24-like
carbonic anhydrase-related protein 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
carbonic anhydrase-related protein 10 isoform X1
carbonic anhydrase-related protein 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
carbonic anhydrase-related protein 10 isoform X2
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase, transcript variant X3
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase, transcript variant X2
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase, transcript variant X1
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase
ubiquitin carboxyl-terminal hydrolase 8-like, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 8-like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 8-like isoform X1
ubiquitin carboxyl-terminal hydrolase 8-like isoform X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6, transcript variant X3
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6, transcript variant X4
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6, transcript variant X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6, transcript variant X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 isoform X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 isoform X1
lisH domain-containing protein ARMC9-like, transcript variant X2
lisH domain-containing protein ARMC9-like, transcript variant X1
lisH domain-containing protein ARMC9-like, transcript variant X3
lisH domain-containing protein ARMC9-like, transcript variant X4
lisH domain-containing protein ARMC9-like isoform X1
lisH domain-containing protein ARMC9-like isoform X3
lisH domain-containing protein ARMC9-like isoform X4
lisH domain-containing protein ARMC9-like isoform X2
putative uncharacterized protein DDB_G0282133, transcript variant X2
putative uncharacterized protein DDB_G0282133, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
putative uncharacterized protein DDB_G0282133 isoform X1
putative uncharacterized protein DDB_G0282133 isoform X2
uncharacterized LOC122570191, transcript variant X1
uncharacterized LOC122570191, transcript variant X2
uncharacterized LOC122570191, transcript variant X3
uncharacterized protein LOC122570191 isoform X1
uncharacterized protein LOC122570191 isoform X3
uncharacterized protein LOC122570191 isoform X2
E3 ubiquitin-protein ligase HUWE1-like, transcript variant X3
E3 ubiquitin-protein ligase HUWE1-like, transcript variant X1
E3 ubiquitin-protein ligase HUWE1-like, transcript variant X2
E3 ubiquitin-protein ligase HUWE1-like isoform X2
E3 ubiquitin-protein ligase HUWE1-like isoform X1
uncharacterized LOC122570330, transcript variant X1
uncharacterized protein LOC122570330 isoform X1
uncharacterized LOC122570330, transcript variant X2
uncharacterized protein LOC122570330 isoform X2
uncharacterized LOC122570133, transcript variant X9
uncharacterized LOC122570133, transcript variant X6
uncharacterized LOC122570133, transcript variant X11
uncharacterized LOC122570133, transcript variant X10
uncharacterized LOC122570133, transcript variant X5
uncharacterized LOC122570133, transcript variant X1
uncharacterized LOC122570133, transcript variant X8
uncharacterized LOC122570133, transcript variant X3
uncharacterized LOC122570133, transcript variant X12
uncharacterized LOC122570133, transcript variant X7
uncharacterized LOC122570133, transcript variant X2
uncharacterized LOC122570133, transcript variant X4
uncharacterized LOC122570274, transcript variant X1
uncharacterized LOC122570274, transcript variant X2
methylated-DNA--protein-cysteine methyltransferase, inducible
protein app1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC122570275 isoform X1
protein app1-like, transcript variant X1
phenylalanine--tRNA ligase alpha subunit, transcript variant X2
phenylalanine--tRNA ligase alpha subunit, transcript variant X1
phenylalanine--tRNA ligase alpha subunit isoform X1
phenylalanine--tRNA ligase alpha subunit, transcript variant X3
phenylalanine--tRNA ligase alpha subunit, transcript variant X4
phenylalanine--tRNA ligase alpha subunit isoform X2
L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
dynein axonemal intermediate chain 3-like, transcript variant X1
dynein axonemal intermediate chain 3-like, transcript variant X2
dynein axonemal intermediate chain 3-like, transcript variant X3
dynein axonemal intermediate chain 3-like isoform X1
dynein axonemal intermediate chain 3-like isoform X2
dynein axonemal intermediate chain 3-like isoform X3
superoxide dismutase [Cu-Zn], chloroplastic-like, transcript variant X1
superoxide dismutase [Cu-Zn], chloroplastic-like, transcript variant X3
superoxide dismutase [Cu-Zn], chloroplastic-like, transcript variant X2
superoxide dismutase [Cu-Zn], chloroplastic-like
S-adenosylmethionine mitochondrial carrier protein-like
hydroxysteroid dehydrogenase-like protein 2
asparagine synthetase domain-containing protein 1
Kv channel-interacting protein 1, transcript variant X3
Kv channel-interacting protein 1, transcript variant X1
Kv channel-interacting protein 1, transcript variant X2
dynein regulatory complex subunit 5-like
mitotic-spindle organizing protein 1-like
serine/threonine-protein kinase 11-interacting protein, transcript variant X4
serine/threonine-protein kinase 11-interacting protein, transcript variant X6
serine/threonine-protein kinase 11-interacting protein, transcript variant X7
serine/threonine-protein kinase 11-interacting protein, transcript variant X10
serine/threonine-protein kinase 11-interacting protein, transcript variant X8
serine/threonine-protein kinase 11-interacting protein, transcript variant X2
serine/threonine-protein kinase 11-interacting protein, transcript variant X1
serine/threonine-protein kinase 11-interacting protein, transcript variant X3
serine/threonine-protein kinase 11-interacting protein, transcript variant X5
serine/threonine-protein kinase 11-interacting protein, transcript variant X9
serine/threonine-protein kinase 11-interacting protein isoform X1
serine/threonine-protein kinase 11-interacting protein isoform X2
serine/threonine-protein kinase 11-interacting protein isoform X3
serine/threonine-protein kinase 11-interacting protein isoform X4
vacuolar protein sorting-associated protein 13, transcript variant X1
vacuolar protein sorting-associated protein 13, transcript variant X2
vacuolar protein sorting-associated protein 13, transcript variant X3
vacuolar protein sorting-associated protein 13, transcript variant X4
vacuolar protein sorting-associated protein 13 isoform X1
vacuolar protein sorting-associated protein 13 isoform X2
vacuolar protein sorting-associated protein 13 isoform X3
vacuolar protein sorting-associated protein 13 isoform X4
tetratricopeptide repeat protein 21B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
proton-associated sugar transporter A, transcript variant X1
proton-associated sugar transporter A, transcript variant X4
proton-associated sugar transporter A, transcript variant X3
proton-associated sugar transporter A, transcript variant X2
proton-associated sugar transporter A isoform X1
proton-associated sugar transporter A isoform X2
synaptic vesicle glycoprotein 2A-like, transcript variant X2
synaptic vesicle glycoprotein 2C-like isoform X2
synaptic vesicle glycoprotein 2A-like, transcript variant X1
synaptic vesicle glycoprotein 2A-like isoform X1
synaptic vesicle glycoprotein 2A-like, transcript variant X3
synaptic vesicle glycoprotein 2A-like isoform X3
uncharacterized LOC122570091, transcript variant X2
uncharacterized LOC122570091, transcript variant X1
uncharacterized protein LOC122570091 isoform X1
uncharacterized LOC122570091, transcript variant X3
uncharacterized protein LOC122570091 isoform X2
citron Rho-interacting kinase-like, transcript variant X2
citron Rho-interacting kinase-like, transcript variant X1
citron Rho-interacting kinase-like isoform X2
citron Rho-interacting kinase-like isoform X1
calcium release-activated calcium channel protein 1-like
signal peptide peptidase-like 3, transcript variant X1
signal peptide peptidase-like 3, transcript variant X2
signal peptide peptidase-like 3, transcript variant X3
signal peptide peptidase-like 3, transcript variant X4
oxysterol-binding protein 1, transcript variant X8
oxysterol-binding protein 1, transcript variant X11
oxysterol-binding protein 1, transcript variant X4
oxysterol-binding protein 1, transcript variant X3
oxysterol-binding protein 1, transcript variant X1
oxysterol-binding protein 1, transcript variant X2
oxysterol-binding protein 1, transcript variant X15
oxysterol-binding protein 1, transcript variant X6
oxysterol-binding protein 1, transcript variant X14
oxysterol-binding protein 1, transcript variant X7
oxysterol-binding protein 1, transcript variant X10
oxysterol-binding protein 1, transcript variant X9
oxysterol-binding protein 1, transcript variant X5
oxysterol-binding protein 1, transcript variant X12
oxysterol-binding protein 1, transcript variant X13
general transcription factor IIH subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X3
venom dipeptidyl peptidase 4-like, transcript variant X3
venom dipeptidyl peptidase 4-like, transcript variant X2
venom dipeptidyl peptidase 4-like, transcript variant X5
venom dipeptidyl peptidase 4-like, transcript variant X4
venom dipeptidyl peptidase 4-like isoform X2
venom dipeptidyl peptidase 4-like, transcript variant X7
venom dipeptidyl peptidase 4-like, transcript variant X9
venom dipeptidyl peptidase 4-like, transcript variant X10
venom dipeptidyl peptidase 4-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
venom dipeptidyl peptidase 4-like, transcript variant X1
venom dipeptidyl peptidase 4-like isoform X1
venom dipeptidyl peptidase 4-like, transcript variant X6
venom dipeptidyl peptidase 4-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
venom dipeptidyl peptidase 4-like isoform X4
DNA-directed RNA polymerase I subunit RPA12
F-box/SPRY domain-containing protein 1, transcript variant X1
F-box/SPRY domain-containing protein 1, transcript variant X3
F-box/SPRY domain-containing protein 1, transcript variant X2
F-box/SPRY domain-containing protein 1 isoform X1
F-box/SPRY domain-containing protein 1 isoform X2
F-box/SPRY domain-containing protein 1 isoform X3
transmembrane protein 164, transcript variant X1
transmembrane protein 164, transcript variant X2
aryl hydrocarbon receptor protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
aryl hydrocarbon receptor protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
aryl hydrocarbon receptor protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
aryl hydrocarbon receptor protein 1-like, transcript variant X4
aryl hydrocarbon receptor protein 1-like isoform X1
aryl hydrocarbon receptor protein 1-like isoform X3
aryl hydrocarbon receptor protein 1-like isoform X2
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
arginine/serine-rich protein PNISR-like, transcript variant X3
arginine/serine-rich protein PNISR-like, transcript variant X2
arginine/serine-rich protein PNISR-like, transcript variant X1
arginine/serine-rich protein PNISR-like isoform X3
arginine/serine-rich protein PNISR-like isoform X2
arginine/serine-rich protein PNISR-like isoform X1
pleckstrin homology domain-containing family G member 5, transcript variant X5
pleckstrin homology domain-containing family G member 5, transcript variant X8
pleckstrin homology domain-containing family G member 5, transcript variant X10
pleckstrin homology domain-containing family G member 5, transcript variant X14
pleckstrin homology domain-containing family G member 5, transcript variant X2
pleckstrin homology domain-containing family G member 5, transcript variant X3
pleckstrin homology domain-containing family G member 5, transcript variant X4
pleckstrin homology domain-containing family G member 5, transcript variant X6
pleckstrin homology domain-containing family G member 5, transcript variant X7
pleckstrin homology domain-containing family G member 5, transcript variant X9
pleckstrin homology domain-containing family G member 5, transcript variant X1
pleckstrin homology domain-containing family G member 5, transcript variant X11
pleckstrin homology domain-containing family G member 5, transcript variant X13
pleckstrin homology domain-containing family G member 5, transcript variant X15
pleckstrin homology domain-containing family G member 5, transcript variant X16
pleckstrin homology domain-containing family G member 5, transcript variant X12
pleckstrin homology domain-containing family G member 5, transcript variant X17
pleckstrin homology domain-containing family G member 5, transcript variant X19
pleckstrin homology domain-containing family G member 5 isoform X1
pleckstrin homology domain-containing family G member 5 isoform X3
pleckstrin homology domain-containing family G member 5 isoform X5
pleckstrin homology domain-containing family G member 5 isoform X4
pleckstrin homology domain-containing family G member 5 isoform X6
pleckstrin homology domain-containing family G member 5 isoform X2
pleckstrin homology domain-containing family G member 5 isoform X9
pleckstrin homology domain-containing family G member 5 isoform X7
pleckstrin homology domain-containing family G member 5, transcript variant X18
pleckstrin homology domain-containing family G member 5 isoform X8
leucine-zipper-like transcriptional regulator 1, transcript variant X2
leucine-zipper-like transcriptional regulator 1, transcript variant X1
leucine-zipper-like transcriptional regulator 1, transcript variant X3
leucine-zipper-like transcriptional regulator 1 isoform X2
leucine-zipper-like transcriptional regulator 1 isoform X1
leucine-zipper-like transcriptional regulator 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein artichoke-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein artichoke-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein artichoke-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein artichoke-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein artichoke-like, transcript variant X4
protein artichoke-like, transcript variant X2
protein artichoke-like, transcript variant X5
protein artichoke-like, transcript variant X9
protein artichoke-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122570440, transcript variant X5
uncharacterized LOC122570440, transcript variant X3
uncharacterized LOC122570440, transcript variant X4
uncharacterized LOC122570440, transcript variant X2
uncharacterized LOC122570440, transcript variant X1
uncharacterized protein LOC122570440 isoform X1
uncharacterized protein LOC122570440 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
signal peptidase complex catalytic subunit SEC11A
probable cytochrome P450 304a1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable cytochrome P450 304a1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable cytochrome P450 304a1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable cytochrome P450 304a1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable cytochrome P450 304a1 isoform X4
probable cytochrome P450 304a1 isoform X3
probable cytochrome P450 304a1 isoform X2
probable cytochrome P450 304a1 isoform X1
disintegrin and metalloproteinase domain-containing protein 10-like, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 10-like, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 10-like, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 10-like isoform X1
disintegrin and metalloproteinase domain-containing protein 10-like isoform X2
LIM domain-binding protein 2, transcript variant X3
LIM domain-binding protein 2, transcript variant X2
LIM domain-binding protein 2, transcript variant X1
LIM domain-binding protein 2, transcript variant X4
uncharacterized protein LOC122570336 isoform X3
uncharacterized protein LOC122570336 isoform X2
uncharacterized protein LOC122570336 isoform X1
protein split ends-like, transcript variant X3
protein split ends-like, transcript variant X1
protein split ends-like, transcript variant X2
uncharacterized LOC122569939, transcript variant X2
uncharacterized LOC122569939, transcript variant X1
uncharacterized LOC122569933, transcript variant X2
uncharacterized LOC122569933, transcript variant X3
uncharacterized LOC122569933, transcript variant X1
uncharacterized LOC122569933, transcript variant X6
uncharacterized LOC122569933, transcript variant X5
uncharacterized LOC122569933, transcript variant X4
uncharacterized protein LOC122569933 isoform X1
uncharacterized protein LOC122569933 isoform X2
uncharacterized protein LOC122569933 isoform X3
transmembrane protein 230, transcript variant X1
transmembrane protein 230, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 79% coverage of the annotated genomic feature by RNAseq alignments
phenoloxidase-activating factor 2-like, transcript variant X1
phenoloxidase-activating factor 2-like, transcript variant X4
phenoloxidase-activating factor 2-like, transcript variant X2
phenoloxidase-activating factor 2-like, transcript variant X3
phenoloxidase-activating factor 2-like isoform X2
phenoloxidase-activating factor 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122569931, transcript variant X5
uncharacterized LOC122569931, transcript variant X1
uncharacterized LOC122569931, transcript variant X2
uncharacterized LOC122569931, transcript variant X3
uncharacterized LOC122569931, transcript variant X4
conserved oligomeric Golgi complex subunit 7, transcript variant X4
conserved oligomeric Golgi complex subunit 7, transcript variant X2
conserved oligomeric Golgi complex subunit 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
conserved oligomeric Golgi complex subunit 7, transcript variant X3
conserved oligomeric Golgi complex subunit 7 isoform X1
conserved oligomeric Golgi complex subunit 7 isoform X2
uncharacterized LOC122569928, transcript variant X4
uncharacterized LOC122569928, transcript variant X3
uncharacterized LOC122569928, transcript variant X7
uncharacterized LOC122569928, transcript variant X1
uncharacterized LOC122569928, transcript variant X2
uncharacterized LOC122569928, transcript variant X6
uncharacterized LOC122569928, transcript variant X5
uncharacterized protein LOC122569928 isoform X2
uncharacterized protein LOC122569928 isoform X1
receptor expression-enhancing protein 1-like, transcript variant X2
receptor expression-enhancing protein 2-like isoform X2
receptor expression-enhancing protein 1-like, transcript variant X1
receptor expression-enhancing protein 2-like isoform X1
receptor expression-enhancing protein 1-like, transcript variant X3
receptor expression-enhancing protein 1-like isoform X3
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X1
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X5
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X4
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X2
probable JmjC domain-containing histone demethylation protein 2C isoform X1
probable JmjC domain-containing histone demethylation protein 2C isoform X5
probable JmjC domain-containing histone demethylation protein 2C isoform X4
probable JmjC domain-containing histone demethylation protein 2C isoform X2
probable JmjC domain-containing histone demethylation protein 2C, transcript variant X3
probable JmjC domain-containing histone demethylation protein 2C isoform X3
tyrosine-protein phosphatase non-receptor type 9
uncharacterized LOC122570182, transcript variant X1
uncharacterized LOC122570182, transcript variant X2
myogenesis-regulating glycosidase, transcript variant X1
uncharacterized protein LOC122570162 isoform X1
nucleoside diphosphate kinase homolog 5-like, transcript variant X2
nucleoside diphosphate kinase homolog 5-like isoform X2
nucleoside diphosphate kinase homolog 5-like, transcript variant X1
nucleoside diphosphate kinase homolog 5-like isoform X1
myogenesis-regulating glycosidase, transcript variant X3
myogenesis-regulating glycosidase, transcript variant X2
myogenesis-regulating glycosidase isoform X2
myogenesis-regulating glycosidase isoform X3
uncharacterized LOC122570171, transcript variant X3
uncharacterized LOC122570171, transcript variant X2
uncharacterized LOC122570171, transcript variant X1
uncharacterized protein LOC122570171 isoform X1
uncharacterized LOC122570171, transcript variant X4
uncharacterized protein LOC122570171 isoform X2
pickpocket protein 19-like, transcript variant X1
pickpocket protein 19-like, transcript variant X2
uncharacterized protein LOC122570175 isoform X2
uncharacterized LOC122570166, transcript variant X1
uncharacterized LOC122570166, transcript variant X2
uncharacterized LOC122570166, transcript variant X3
uncharacterized LOC122570166, transcript variant X4
uncharacterized protein LOC122570166 isoform X1
uncharacterized LOC122570166, transcript variant X5
uncharacterized protein LOC122570166 isoform X2
beta-1,4-galactosyltransferase 7, transcript variant X2
beta-1,4-galactosyltransferase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 75% coverage of the annotated genomic feature by RNAseq alignments
calponin homology domain-containing protein DDB_G0272472-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
probable 39S ribosomal protein L45, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X4
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X5
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X2
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X6
tyrosine-protein kinase transmembrane receptor Ror isoform X1
tyrosine-protein kinase transmembrane receptor Ror isoform X2
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tyrosine-protein kinase transmembrane receptor Ror isoform X3
uncharacterized LOC122570165, transcript variant X2
uncharacterized LOC122570165, transcript variant X1
uncharacterized LOC122570165, transcript variant X5
uncharacterized LOC122570165, transcript variant X4
uncharacterized LOC122570165, transcript variant X3
uncharacterized protein LOC122570165 isoform X1
uncharacterized protein LOC122570165 isoform X3
uncharacterized protein LOC122570165 isoform X2
uncharacterized LOC122570165, transcript variant X7
uncharacterized protein LOC122570165 isoform X5
uncharacterized LOC122570165, transcript variant X10
uncharacterized LOC122570165, transcript variant X9
uncharacterized protein LOC122570165 isoform X8
uncharacterized protein LOC122570165 isoform X7
uncharacterized LOC122570165, transcript variant X8
uncharacterized protein LOC122570165 isoform X6
uncharacterized LOC122570165, transcript variant X6
uncharacterized protein LOC122570165 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
plant intracellular Ras-group-related LRR protein 1-like, transcript variant X3
plant intracellular Ras-group-related LRR protein 1-like, transcript variant X4
plant intracellular Ras-group-related LRR protein 1-like, transcript variant X1
plant intracellular Ras-group-related LRR protein 1-like, transcript variant X2
plant intracellular Ras-group-related LRR protein 1-like isoform X3
plant intracellular Ras-group-related LRR protein 1-like isoform X4
plant intracellular Ras-group-related LRR protein 1-like isoform X1
plant intracellular Ras-group-related LRR protein 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122569960, transcript variant X1
uncharacterized LOC122569960, transcript variant X2
uncharacterized protein LOC122569960 isoform X1
uncharacterized protein LOC122569960 isoform X2
protein O-GlcNAcase, transcript variant X2
protein O-GlcNAcase, transcript variant X5
protein O-GlcNAcase, transcript variant X4
protein O-GlcNAcase, transcript variant X6
protein O-GlcNAcase, transcript variant X3
protein O-GlcNAcase, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X3
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X4
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X6
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X4
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X6
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X3
uncharacterized LOC122570232, transcript variant X2
uncharacterized LOC122570232, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X5
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 isoform X5
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X7
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X7
uncharacterized LOC122570231, transcript variant X2
uncharacterized LOC122570231, transcript variant X1
uncharacterized LOC122570231, transcript variant X3
uncharacterized protein LOC122570231 isoform X2
uncharacterized protein LOC122570231 isoform X1
uncharacterized protein LOC122570231 isoform X3
zinc finger HIT domain-containing protein 2, transcript variant X2
zinc finger HIT domain-containing protein 2, transcript variant X1
zinc finger HIT domain-containing protein 2
phosphatidylinositol 4-kinase alpha, transcript variant X1
phosphatidylinositol 4-kinase alpha, transcript variant X2
phosphatidylinositol 4-kinase alpha isoform X1
phosphatidylinositol 4-kinase alpha isoform X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7-like
superoxide dismutase [Cu-Zn], transcript variant X1
superoxide dismutase [Cu-Zn], transcript variant X2
uncharacterized LOC122569950, transcript variant X1
uncharacterized LOC122569950, transcript variant X2
uncharacterized LOC122569950, transcript variant X3
uncharacterized protein LOC122569950 isoform X1
uncharacterized protein LOC122569950 isoform X2
MAM and LDL-receptor class A domain-containing protein 1-like, transcript variant X1
MAM and LDL-receptor class A domain-containing protein 1-like, transcript variant X2
MAM and LDL-receptor class A domain-containing protein 1-like isoform X1
MAM and LDL-receptor class A domain-containing protein 1-like isoform X2
uncharacterized LOC122569979, transcript variant X2
uncharacterized protein LOC122569979 isoform X2
uncharacterized LOC122569979, transcript variant X1
uncharacterized protein LOC122569979 isoform X1
uncharacterized LOC122569979, transcript variant X3
uncharacterized protein LOC122569979 isoform X3
BTB/POZ domain-containing protein 7, transcript variant X4
BTB/POZ domain-containing protein 7, transcript variant X1
BTB/POZ domain-containing protein 7, transcript variant X2
BTB/POZ domain-containing protein 7, transcript variant X3
BTB/POZ domain-containing protein 7 isoform X2
BTB/POZ domain-containing protein 7 isoform X1
BTB/POZ domain-containing protein 7, transcript variant X5
BTB/POZ domain-containing protein 7 isoform X3
GTP-binding protein 2, transcript variant X3
GTP-binding protein 2, transcript variant X4
GTP-binding protein 2, transcript variant X1
GTP-binding protein 2, transcript variant X2
leukocyte elastase inhibitor-like, transcript variant X1
leukocyte elastase inhibitor-like, transcript variant X2
uncharacterized LOC122569907, transcript variant X1
uncharacterized LOC122569907, transcript variant X2
DEAD-box ATP-dependent RNA helicase 20-like
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1-like, transcript variant X1
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1-like, transcript variant X2
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1-like isoform X2
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1-like isoform X1
nudC domain-containing protein 1, transcript variant X2
nudC domain-containing protein 1, transcript variant X1
nudC domain-containing protein 1 isoform X2
nudC domain-containing protein 1 isoform X1
uncharacterized LOC122569898, transcript variant X2
uncharacterized LOC122569898, transcript variant X1
uncharacterized protein LOC122569898 isoform X2
uncharacterized protein LOC122569898 isoform X1
uncharacterized LOC122569898, transcript variant X3
protein unc-13 homolog 4B, transcript variant X9
protein unc-13 homolog 4B, transcript variant X5
protein unc-13 homolog 4B, transcript variant X1
protein unc-13 homolog 4B, transcript variant X3
protein unc-13 homolog 4B, transcript variant X2
protein unc-13 homolog 4B, transcript variant X7
protein unc-13 homolog 4B, transcript variant X11
protein unc-13 homolog 4B, transcript variant X4
protein unc-13 homolog 4B, transcript variant X10
protein unc-13 homolog 4B, transcript variant X6
protein unc-13 homolog 4B, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
dedicator of cytokinesis protein 7, transcript variant X3
dedicator of cytokinesis protein 7, transcript variant X2
dedicator of cytokinesis protein 7, transcript variant X1
dedicator of cytokinesis protein 7 isoform X2
dedicator of cytokinesis protein 7 isoform X1
dedicator of cytokinesis protein 7 isoform X3
uncharacterized LOC122570430, transcript variant X2
uncharacterized LOC122570430, transcript variant X1
uncharacterized protein LOC122570430 isoform X2
uncharacterized protein LOC122570430 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mitotic spindle assembly checkpoint protein MAD1, transcript variant X1
mitotic spindle assembly checkpoint protein MAD1, transcript variant X2
mitotic spindle assembly checkpoint protein MAD1, transcript variant X3
mitotic spindle assembly checkpoint protein MAD1 isoform X1
mitotic spindle assembly checkpoint protein MAD1 isoform X2
GATOR complex protein WDR24, transcript variant X1
GATOR complex protein WDR24, transcript variant X3
GATOR complex protein WDR24, transcript variant X2
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X3
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X2
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X1
gamma-aminobutyric acid type B receptor subunit 2 isoform X2
gamma-aminobutyric acid type B receptor subunit 2 isoform X1
glucose dehydrogenase [FAD, quinone]-like
rh5-interacting protein-like, transcript variant X5
rh5-interacting protein-like, transcript variant X1
rh5-interacting protein-like, transcript variant X4
rh5-interacting protein-like, transcript variant X2
rh5-interacting protein-like, transcript variant X3
prion-like-(Q/N-rich) domain-bearing protein 25
39S ribosomal protein L51, mitochondrial
dipeptidyl peptidase 9, transcript variant X2
dipeptidyl peptidase 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RNA-binding protein Musashi homolog 2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: RNA-binding protein Musashi homolog 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
retinol dehydrogenase 14, transcript variant X1
retinol dehydrogenase 14, transcript variant X4
retinol dehydrogenase 14, transcript variant X2
retinol dehydrogenase 14, transcript variant X3
uncharacterized LOC122570033, transcript variant X3
uncharacterized LOC122570033, transcript variant X1
uncharacterized LOC122570033, transcript variant X2
uncharacterized LOC122570033, transcript variant X4
uncharacterized LOC122570033, transcript variant X5
uncharacterized LOC122570129, transcript variant X3
uncharacterized LOC122570129, transcript variant X1
uncharacterized LOC122570129, transcript variant X2
octopamine receptor beta-2R-like, transcript variant X6
octopamine receptor beta-2R-like, transcript variant X7
octopamine receptor beta-2R-like, transcript variant X9
octopamine receptor beta-2R-like, transcript variant X11
octopamine receptor beta-2R-like, transcript variant X4
octopamine receptor beta-2R-like, transcript variant X1
octopamine receptor beta-2R-like, transcript variant X10
octopamine receptor beta-2R-like, transcript variant X2
octopamine receptor beta-2R-like, transcript variant X5
octopamine receptor beta-2R-like, transcript variant X8
octopamine receptor beta-2R-like, transcript variant X3
octopamine receptor beta-2R-like isoform X2
octopamine receptor beta-2R-like isoform X1
octopamine receptor beta-2R-like isoform X4
octopamine receptor beta-2R-like isoform X3
facilitated trehalose transporter Tret1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
vicilin-like seed storage protein At2g18540
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 34% coverage of the annotated genomic feature by RNAseq alignments
myb-like protein X, transcript variant X2
BTB/POZ domain-containing protein KCTD9, transcript variant X3
BTB/POZ domain-containing protein KCTD9, transcript variant X2
BTB/POZ domain-containing protein KCTD9, transcript variant X1
myb-like protein X, transcript variant X1
myb-like protein X, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
myb-like protein X, transcript variant X5
myb-like protein X, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
protein ATP6V1FNB-like, transcript variant X1
protein ATP6V1FNB-like, transcript variant X2
uncharacterized LOC122570300, transcript variant X2
uncharacterized LOC122570300, transcript variant X1
uncharacterized protein LOC122570300 isoform X2
uncharacterized protein LOC122570300 isoform X1
ATP-dependent RNA helicase SUV3 homolog, mitochondrial, transcript variant X2
ATP-dependent RNA helicase SUV3 homolog, mitochondrial, transcript variant X1
ATP-dependent RNA helicase SUV3 homolog, mitochondrial
uncharacterized LOC122570298, transcript variant X3
uncharacterized LOC122570298, transcript variant X2
uncharacterized LOC122570298, transcript variant X1
CDK5 regulatory subunit-associated protein 3
transmembrane emp24 domain-containing protein 7-like
uncharacterized LOC122570354, transcript variant X1
uncharacterized LOC122570354, transcript variant X6
uncharacterized LOC122570354, transcript variant X7
uncharacterized LOC122570354, transcript variant X4
uncharacterized LOC122570354, transcript variant X9
uncharacterized LOC122570354, transcript variant X2
uncharacterized LOC122570354, transcript variant X3
uncharacterized protein LOC122570354 isoform X1
uncharacterized protein LOC122570354 isoform X4
uncharacterized protein LOC122570354 isoform X5
uncharacterized protein LOC122570354 isoform X2
uncharacterized protein LOC122570354 isoform X7
uncharacterized LOC122570354, transcript variant X5
uncharacterized LOC122570354, transcript variant X8
uncharacterized protein LOC122570354 isoform X3
uncharacterized protein LOC122570354 isoform X6
WD repeat-containing protein 61, transcript variant X2
WD repeat-containing protein 61, transcript variant X3
WD repeat-containing protein 61, transcript variant X1
WD repeat-containing protein 61 isoform X2
WD repeat-containing protein 61 isoform X1
28S ribosomal protein S27, mitochondrial
coiled-coil domain-containing protein 22 homolog, transcript variant X1
coiled-coil domain-containing protein 22 homolog, transcript variant X2
coiled-coil domain-containing protein 22 homolog isoform X1
coiled-coil domain-containing protein 22 homolog isoform X2
DENN domain-containing protein 5B, transcript variant X5
DENN domain-containing protein 5B, transcript variant X1
DENN domain-containing protein 5B, transcript variant X2
DENN domain-containing protein 5B, transcript variant X3
DENN domain-containing protein 5B, transcript variant X6
DENN domain-containing protein 5B, transcript variant X4
DENN domain-containing protein 5B isoform X4
DENN domain-containing protein 5A isoform X1
DENN domain-containing protein 5A isoform X2
DENN domain-containing protein 5B isoform X5
DENN domain-containing protein 5A isoform X3
uncharacterized LOC122569894, transcript variant X1
uncharacterized LOC122569894, transcript variant X2
protein spaetzle-like, transcript variant X4
protein spaetzle-like, transcript variant X3
protein spaetzle-like, transcript variant X1
protein spaetzle-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122570273, transcript variant X11
uncharacterized LOC122570273, transcript variant X12
uncharacterized LOC122570273, transcript variant X13
uncharacterized LOC122570273, transcript variant X9
uncharacterized LOC122570273, transcript variant X10
uncharacterized LOC122570273, transcript variant X6
uncharacterized LOC122570273, transcript variant X8
uncharacterized LOC122570273, transcript variant X5
uncharacterized LOC122570273, transcript variant X3
uncharacterized LOC122570273, transcript variant X15
uncharacterized LOC122570273, transcript variant X2
uncharacterized LOC122570273, transcript variant X7
uncharacterized LOC122570273, transcript variant X4
uncharacterized LOC122570273, transcript variant X1
uncharacterized LOC122570273, transcript variant X14
uncharacterized protein LOC122570273 isoform X1
uncharacterized protein LOC122570273 isoform X2
inositol monophosphatase 2-like, transcript variant X2
inositol monophosphatase 2-like, transcript variant X1
inositol monophosphatase 2-like, transcript variant X3
inositol monophosphatase 2-like isoform X1
inositol monophosphatase 2-like isoform X2
inositol monophosphatase 2-like isoform X3
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like, transcript variant X3
facilitated trehalose transporter Tret1-like isoform X1
facilitated trehalose transporter Tret1-like isoform X2
facilitated trehalose transporter Tret1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 63% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122569948, transcript variant X3
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122569945, transcript variant X1
uncharacterized LOC122569948, transcript variant X2
uncharacterized protein LOC122569945 isoform X1
uncharacterized LOC122569948, transcript variant X1
uncharacterized LOC122569948, transcript variant X4
uncharacterized LOC122569948, transcript variant X8
uncharacterized LOC122569948, transcript variant X5
uncharacterized LOC122569948, transcript variant X7
uncharacterized LOC122569948, transcript variant X6
uncharacterized protein LOC122569948 isoform X1
uncharacterized protein LOC122569948 isoform X2
uncharacterized LOC122569945, transcript variant X2
uncharacterized LOC122569945, transcript variant X3
uncharacterized protein LOC122569945 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122570134, transcript variant X4
uncharacterized LOC122570134, transcript variant X5
uncharacterized LOC122570134, transcript variant X1
uncharacterized LOC122570134, transcript variant X2
uncharacterized LOC122570134, transcript variant X3
uncharacterized LOC122570432, transcript variant X2
uncharacterized LOC122570432, transcript variant X1
uncharacterized protein LOC122570432 isoform X2
uncharacterized protein LOC122570432 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC122570294
COORDINATES: nucleotide motif:Rfam:12.0:RF00619